Page 1 | Search Results | ASH Clinical News | American Society of Hematology

1-20 of 107

Sort by

Sort Order Select

News

Small Activating RNA-Mediated Induction of HBG Gene Via In Vivo Delivery Shows Potential in SCD

Katie Robinson

Abstract

View News titled, Small Activating RNA-Mediated Induction of HBG Gene Via In Vivo Delivery Shows Potential in SCD

News

Trispecific Antibody Safe With High Efficacy in Phase I R/R MM Study

Katie Robinson

Abstract

View News titled, Trispecific Antibody Safe With High Efficacy in Phase I R/R MM Study

News

Pneumococcal Meningitis Mortality Remains High in Children in France With SCD

Katie Robinson

Abstract

View News titled, Pneumococcal Meningitis Mortality Remains High in Children in France With SCD

News

Low Rates of High-Grade Toxicities Seen With Fresh CAR T-Cell Therapy in R/R NHL

Katie Robinson

Abstract

View News titled, Low Rates of High-Grade Toxicities Seen With Fresh CAR T-Cell Therapy in R/R NHL

News

Circulating Tumor DNA Analysis Identifies Classical Hodgkin Lymphoma Genotypes

Katie Robinson

Abstract

View News titled, Circulating Tumor DNA Analysis Identifies Classical Hodgkin Lymphoma Genotypes

News

Daratumumab Shows Clinical Activity, No New Safety Concerns With Extended Use in Intermediate/High-Risk Smoldering MM

Katie Robinson

Abstract

View News titled, Daratumumab Shows Clinical Activity, No New Safety Concerns With Extended Use in Intermediate/High-Risk Smoldering MM

News

Cilta-Cel Shows Superior Efficacy, Survival Over Ide-Cel, but Higher Toxicity in R/R MM

Katie Robinson

Abstract

View News titled, Cilta-Cel Shows Superior Efficacy, Survival Over Ide-Cel, but Higher Toxicity in R/R MM

News

Cyclophosphamide May Mitigate Movement, Neurocognitive Treatment-Emergent Adverse Events Following Cilta-Cel for R/R MM

Katie Robinson

Abstract

View News titled, Cyclophosphamide May Mitigate Movement, Neurocognitive Treatment-Emergent Adverse Events Following Cilta-Cel for R/R MM

News

Clonal Hematopoiesis Linked to Increased Risk for Heart Failure, Non-Relapse Mortality After AHCT for Lymphoma

Katie Robinson

Abstract

View News titled, Clonal Hematopoiesis Linked to Increased Risk for Heart Failure, Non-Relapse Mortality After AHCT for Lymphoma

News

DNMT3A Mutations Found in Frequent Blood Donors, But No Clonal Hematopoiesis Increase

Katie Robinson

Abstract

View News titled, DNMT3A Mutations Found in Frequent Blood Donors, But No Clonal Hematopoiesis Increase

News

Front-Line Brentuximab Vedotin, Nivolumab Plus Chemotherapy Shows Durable Response, Acceptable Safety in Advanced cHL

Katie Robinson

Abstract

View News titled, Front-Line Brentuximab Vedotin, Nivolumab Plus Chemotherapy Shows Durable Response, Acceptable Safety in Advanced cHL

News

Clonal Hematopoiesis Associated With Cytopenias After CAR-T Therapy for MM

Katie Robinson

Abstract

View News titled, Clonal Hematopoiesis Associated With Cytopenias After CAR-T Therapy for MM

News

Pacritinib Response Linked to Survival in Myelofibrosis With Thrombocytopenia

Katie Robinson

Abstract

View News titled, Pacritinib Response Linked to Survival in Myelofibrosis With Thrombocytopenia

News

Odronextamab Monotherapy Appears Safe, Effective in R/R DLBCL With Progression After CAR-T

Katie Robinson

Abstract

View News titled, Odronextamab Monotherapy Appears Safe, Effective in R/R DLBCL With Progression After CAR-T

News

Study of LBCL Confirms Prognostic Value of ctDNA in Second-Line Liso-Cel Versus Standard of Care

Katie Robinson

Abstract

View News titled, Study of LBCL Confirms Prognostic Value of ctDNA in Second-Line Liso-Cel Versus Standard of Care

News

Clonal Hematopoiesis May Prolong Cytopenias After CAR-T Therapy for MM

Katie Robinson

Abstract

View News titled, Clonal Hematopoiesis May Prolong Cytopenias After CAR-T Therapy for MM

News

CAR-T Shows Acceptable Efficacy, Safety in Phase II R/R T-ALL/LBL Study

Katie Robinson

Abstract

View News titled, CAR-T Shows Acceptable Efficacy, Safety in Phase II R/R T-ALL/LBL Study

News

Cilta-Cel Treatment in Lenalidomide-Refractory MM Results in High Rates of MRD Negativity

Katie Robinson

Abstract

View News titled, Cilta-Cel Treatment in Lenalidomide-Refractory MM Results in High Rates of MRD Negativity

News

Study Highlights Characteristics of Post-CAR-T Treatment–Related Myeloid Neoplasms

Katie Robinson

Abstract

View News titled, Study Highlights Characteristics of Post-CAR-T Treatment–Related Myeloid Neoplasms

News

Relapse-Free Survival Progressively Shortens in Black Patients With Rituximab-Treated iTTP

Katie Robinson

Abstract

View News titled, Relapse-Free Survival Progressively Shortens in Black Patients With Rituximab-Treated iTTP

Update search

NARROW

Publications

Format

Topics

Date

Availability

Small Activating RNA-Mediated Induction of HBG Gene Via In Vivo Delivery Shows Potential in SCD

Trispecific Antibody Safe With High Efficacy in Phase I R/R MM Study

Pneumococcal Meningitis Mortality Remains High in Children in France With SCD

Low Rates of High-Grade Toxicities Seen With Fresh CAR T-Cell Therapy in R/R NHL

Circulating Tumor DNA Analysis Identifies Classical Hodgkin Lymphoma Genotypes

Daratumumab Shows Clinical Activity, No New Safety Concerns With Extended Use in Intermediate/High-Risk Smoldering MM

Cilta-Cel Shows Superior Efficacy, Survival Over Ide-Cel, but Higher Toxicity in R/R MM

Cyclophosphamide May Mitigate Movement, Neurocognitive Treatment-Emergent Adverse Events Following Cilta-Cel for R/R MM

Clonal Hematopoiesis Linked to Increased Risk for Heart Failure, Non-Relapse Mortality After AHCT for Lymphoma

DNMT3A Mutations Found in Frequent Blood Donors, But No Clonal Hematopoiesis Increase

Front-Line Brentuximab Vedotin, Nivolumab Plus Chemotherapy Shows Durable Response, Acceptable Safety in Advanced cHL

Clonal Hematopoiesis Associated With Cytopenias After CAR-T Therapy for MM

Pacritinib Response Linked to Survival in Myelofibrosis With Thrombocytopenia

Odronextamab Monotherapy Appears Safe, Effective in R/R DLBCL With Progression After CAR-T

Study of LBCL Confirms Prognostic Value of ctDNA in Second-Line Liso-Cel Versus Standard of Care

Clonal Hematopoiesis May Prolong Cytopenias After CAR-T Therapy for MM

CAR-T Shows Acceptable Efficacy, Safety in Phase II R/R T-ALL/LBL Study

Cilta-Cel Treatment in Lenalidomide-Refractory MM Results in High Rates of MRD Negativity

Study Highlights Characteristics of Post-CAR-T Treatment–Related Myeloid Neoplasms

Relapse-Free Survival Progressively Shortens in Black Patients With Rituximab-Treated iTTP

ASH Publications

American Society of Hematology

Update search

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only